Princeton Capital Management LLC Tff Pharmaceuticals, Inc. Transaction History

Princeton Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.31 - $0.48 $713 - $1,104	-2,302 Reduced 11.25%	18,161 $6,000
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $33,112 - $59,294	-77,006 Reduced 79.01%	20,463 $9,000
Q1 2023 May 01, 2023	SELL	$0.62 - $1.1 $2,467 - $4,378	-3,980 Reduced 3.92%	97,469 $66,000
Q4 2022 Jan 31, 2023	SELL	$0.84 - $100.75 $29,505 - $3.54 Million	-35,125 Reduced 25.72%	101,449 $106,000
Q3 2022 Nov 10, 2022	BUY	$4.61 - $116.0 $14,466 - $364,008	3,138 Added 2.35%	136,574 $554,000
Q2 2022 Aug 15, 2022	BUY	$3.99 - $7.22 $29,797 - $53,918	7,468 Added 5.93%	133,436 $754,000
Q1 2022 May 11, 2022	BUY	$5.28 - $9.17 $1,040 - $1,806	197 Added 0.16%	125,968 $795,000
Q4 2021 Feb 09, 2022	SELL	$6.86 - $9.65 $15,544 - $21,866	-2,266 Reduced 1.77%	125,771 $1.12 Million
Q3 2021 Nov 10, 2021	BUY	$7.21 - $10.49 $128,013 - $186,249	17,755 Added 16.1%	128,037 $988,000
Q2 2021 Aug 11, 2021	BUY	$8.48 - $13.61 $935,191 - $1.5 Million	110,282 New	110,282 $1.06 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.